Osumili, B.* et al. Efficacy and safety of tirzepatide compared with GLP-1 RAs in patients with type 2 diabetes treated with basal insulin: A network meta-analysis. Diabetes Ther. 16, 1279-1311 (2025)
Gutgesell, R.M. ; Nogueiras, R.* ; Tschöp, M.H. & Müller, T.D. Dual and triple incretin-based co-agonists: Novel therapeutics for obesity and diabetes. Diabetes Ther. 15, 1069-1084 (2024)
Matthews, D.* et al. Insights from VERIFY: Early combination therapy provides better glycaemic durability than a stepwise approach in newly diagnosed type 2 diabetes. Diabetes Ther. 11, 2465-2476 (2020)
Modafferi, S.* et al. Clinical trials on diabetic nephropathy: A cross-sectional analysis. Diabetes Ther. 10, 229-243 (2019)